Seaport Therapeutics, Inc. Common Stock (SPTX) — Cash Flow-to-Debt Ratio
Seaport Therapeutics, Inc. Common Stock (SPTX) has a Cash Flow-to-Debt Ratio of -0.23x as of December 2025, meaning its operating cash flow of $-77.94 Million could theoretically repay 0% of its total liabilities ($341.55 Million) in one year. See SPTX working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Seaport Therapeutics, Inc. Common Stock Cash Flow-to-Debt Ratio (2024–2025)
Historical debt coverage capacity for Seaport Therapeutics, Inc. Common Stock across 2 annual periods. Also explore Seaport Therapeutics, Inc. Common Stock annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Seaport Therapeutics, Inc. Common Stock (2024–2025)
Year-by-year debt coverage analysis for Seaport Therapeutics, Inc. Common Stock. For market capitalisation and broader financial context, see market cap of Seaport Therapeutics, Inc. Common Stock.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.23x | $-77.94 Million | $341.55 Million | ▼ -162.3% |
| 2024 | -0.09x | $-29.63 Million | $340.63 Million | — |